Medistim

Director's Dealing • Feb 27, 2015

Transfer of shares to CEO Medistim ASA

Transfer of shares to CEO Medistim ASA

Medistim ASA has transferred 15,000 shares to

Medistim CEO Kari Krogstad as part of her

compensation for 2015. It is part of her agreement

with the Board of Medistim that she receives 15,000

shares if she is in position as CEO until 1st of

January 2015. The agreement has been previously

described in the Company's Annual Report for 2013.

Medistims share price as of 01.01.2015 was 27.50 so

the shares are transferred at this cost. Medistim

ASA has 236,000 own shares and after the transfer to

Kari Krogstad the company has 221,000 own shares

shares.

Krogstad agreement gives her additional 10,000

shares in Medistim if she is in position until 2016

and another 10,000 shares if she is in position

until 2017. This is also described in the Annual

Report for 2013. The Board of Medistim ASA has

decided to award Kari Krogstad with another 12,500

shares if she is in position as CEO until 2018.

Kari Krogstad has after the latest transfer 55,000

shares in Medistim ASA